ALX Oncology
0 followers
‌
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Industries
Headquarters
Employees
Links
Org chart
Jaume Pons
President & Chief Scientific Officer
Jaume Pons
Collapse
Peter GarcÃa
Chief Financial Officer
Sophia Randolph
Chief Medical Officer
Jeanne Jew
Chief Business Officer
Chris Byrd
General Counsel
Athanasios Tsiatis
SVP, Clinical Development
Yeong-Liang Lin
SVP, Drug Safety & Pharmacovigilance
Michael Chang
VP, Operations
Hank Stern
VP, Chemistry, Manufacturing & Controls
Susan Vermeir
VP, Regulatory Affairs & Quality
Hadi Falahatpisheh
VP, Preclinical Development
Marija Vrljic
VP, Antibody Technologies
Sue Naim
VP, Clinical Operations
